A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
for Chronic Kidney Disease
5 locations incl. Glendale
Sponsor: AstraZeneca
Sex: All·Age: 18 - 75·Accepts healthy volunteers
Code: NCT07024823·Phase 1·Recruiting